Less Ads, More Data, More Tools Register for FREE

Pin to quick picksActiveops Regulatory News (AOM)

Share Price Information for Activeops (AOM)

Share Price is delayed by 15 minutes
Get Live Data
259.50    -0.50 (-0.19%)
Bid:
255.00
Ask:
264.00
Spread: 9.00 (3.529%)
Market Cap: £185.42m
AOM Live PriceLast checked at - London Stock Exchange

Intraday Activeops Share Chart

Block Listing Application

22 Jul 2025 09:37

RNS Number : 0558S
ActiveOps PLC
22 July 2025
 

22 July 2025 

 

ActiveOps plc 

("ActiveOps", the "Company" or the "Group") 

 

Block Listing Application

 

ActiveOps plc (AIM: AOM), a leading provider of Decision Intelligence software for service operations, announces that an application has been made to the London Stock Exchange for a block admission of 113,692 ordinary shares of 0.01 pence each in the Company (the "Ordinary Shares") to trading on AIM. These new Ordinary shares will be issued from time to time pursuant to the exercise of share options under the Company's Performance Share Plan 2021.

 

The Ordinary Shares held under the block admission will be allotted and issued in due course in accordance with the rules of the respective scheme(s) and will rank pari passu in all respects with the existing Ordinary Shares in issue. It is expected that admission of the Ordinary Shares under the block admission will become effective at 8.00 am on 25 July 2025. There is no change to the Group's issued share capital as a result of the Block Admission.

 

 

For more information, please contact:

 

ActiveOps

Via Alma

Richard Jeffery, Executive Chair

www.activeops.com

Emma Salthouse, Chief Financial Officer

 

Investec Bank plc

+44 (0)20 7597 5970

Nominated Adviser and Joint Broker

Patrick Robb / Nick Prowting / James Smith

 

Canaccord Genuity Limited

+44 (0)20 7523 8000

Joint Broker

Simon Bridges / Harry Gooden / Harry Rees

 

Alma Strategic Communications

+ 44(0) 203 405 0205

Caroline Forde / Will Ellis Hancock / Louisa El-Ahwal

 

 

About ActiveOps

ActiveOps is a Software as a Service business, dedicated to helping organisations create more value from their service operations. ActiveOps' Decision Intelligence software solutions are specifically designed to support leaders with the vast number of decisions they make daily in the running their operations. Our customers make better decisions and consume less time and effort making them. The outcomes are significantly improved turnaround times and double-digit improvements in productivity with backlogs of work materially reduced. Customers also leverage the capacity created to invest in transformation and development, and more efficiently utilise resources.

The Company's AI-powered SaaS solutions are underpinned by 15+ years of operational data and its AOM methodology which is proven to enhance cross departmental decision-making.

The Company has approximately 190 employees, serving a global base of enterprise customers from offices in the UK, Ireland, USA, Canada, Australia, India, and South Africa. The Group's customers are predominantly in the banking, insurance, healthcare administration and business process outsourcing (BPO) sectors, including Nationwide, TD Bank, Elevance and Xchanging.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSEAPXAADKSEEA
Date   Source Headline
20th Feb 202412:02 pmRNSDirector/PDMR Dealing
20th Feb 20247:15 amRNSHolding(s) in Company
30th Jan 202410:49 amRNSDirector/PDMR Dealing
19th Jan 20241:00 pmRNSDirector/PDMR Dealing
28th Dec 20233:32 pmRNSDirector/PDMR Dealing
19th Dec 202312:12 pmRNSDirector/PDMR Dealing
7th Dec 20237:00 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSBoard Succession Planning
27th Nov 20234:20 pmRNSDirector/PDMR Dealing
21st Nov 20233:55 pmRNSDirector/PDMR Dealing
14th Nov 20237:00 amRNSInterim Results
10th Nov 20237:00 amRNSNotice of Investor Presentation
8th Nov 20234:29 pmRNSDirector/PDMR Dealing
18th Oct 20234:59 pmRNSDirector/PDMR Dealing
18th Oct 20237:00 amRNSTrading Update and Notice of Half Year Results
28th Sep 202312:48 pmRNSResult of AGM
26th Sep 202311:52 amRNSDirector/PDMR Dealing
26th Sep 20237:00 amRNSLaunch of ControliQ Series 3
18th Sep 20233:01 pmRNSDirector/PDMR Dealing
5th Sep 20237:00 amRNSAppointment of Chief Financial Officer
24th Aug 20232:31 pmRNSDirector/PDMR Dealing
23rd Aug 20235:58 pmRNSPublication of Annual Report and Notice of AGM
18th Aug 20234:59 pmRNSDirector/PDMR Dealing
27th Jul 20231:54 pmRNSHolding(s) in Company
26th Jul 20232:16 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSDirector/PDMR Dealing
18th Jul 20233:46 pmRNSDirector/PDMR Dealing
4th Jul 20237:00 amRNSResults for the year ended 31 March 2023
28th Jun 20234:36 pmRNSDirector/PDMR Dealing
26th Jun 20237:00 amRNSNotice of Results and Investor Presentation
19th Jun 20233:13 pmRNSDirector/PDMR Dealing
25th May 202311:20 amRNSDirector/PDMR Dealing
19th May 20231:14 pmRNSDirector/PDMR Dealing
25th Apr 20237:00 amRNSFull Year Trading Update
24th Apr 20234:41 pmRNSDirector/PDMR Dealing
21st Apr 202311:45 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
27th Mar 20231:14 pmRNSDirector/PDMR Dealing
21st Mar 20237:00 amRNSDirector/PDMR Dealing
27th Feb 20237:00 amRNSDirector/PDMR Dealing
20th Feb 202310:38 amRNSDirector/PDMR Dealing
24th Jan 20231:27 pmRNSDirector/PDMR Dealing
18th Jan 202311:18 amRNSDirector/PDMR Dealing
29th Dec 202212:48 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
16th Dec 20227:00 amRNSDirectorate Change
7th Dec 20225:38 pmRNSHolding(s) in Company
1st Dec 202212:01 pmRNSHolding(s) in Company
29th Nov 20227:00 amRNSInterim Results
25th Nov 202210:12 amRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.